1. Home
  2. KFY vs LNTH Comparison

KFY vs LNTH Comparison

Compare KFY & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFY
  • LNTH
  • Stock Information
  • Founded
  • KFY 1969
  • LNTH 1956
  • Country
  • KFY United States
  • LNTH United States
  • Employees
  • KFY N/A
  • LNTH N/A
  • Industry
  • KFY Diversified Commercial Services
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KFY Consumer Discretionary
  • LNTH Health Care
  • Exchange
  • KFY Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • KFY 3.9B
  • LNTH 3.6B
  • IPO Year
  • KFY 1999
  • LNTH 2015
  • Fundamental
  • Price
  • KFY $73.23
  • LNTH $54.75
  • Analyst Decision
  • KFY Buy
  • LNTH Strong Buy
  • Analyst Count
  • KFY 2
  • LNTH 6
  • Target Price
  • KFY $80.00
  • LNTH $105.50
  • AVG Volume (30 Days)
  • KFY 287.8K
  • LNTH 1.8M
  • Earning Date
  • KFY 09-09-2025
  • LNTH 11-05-2025
  • Dividend Yield
  • KFY 2.62%
  • LNTH N/A
  • EPS Growth
  • KFY 42.44
  • LNTH N/A
  • EPS
  • KFY 4.60
  • LNTH 3.77
  • Revenue
  • KFY $2,730,088,000.00
  • LNTH $1,520,653,000.00
  • Revenue This Year
  • KFY $3.15
  • LNTH N/A
  • Revenue Next Year
  • KFY $4.79
  • LNTH $3.24
  • P/E Ratio
  • KFY $15.95
  • LNTH $14.48
  • Revenue Growth
  • KFY N/A
  • LNTH 5.75
  • 52 Week Low
  • KFY $59.23
  • LNTH $47.25
  • 52 Week High
  • KFY $80.64
  • LNTH $118.21
  • Technical
  • Relative Strength Index (RSI)
  • KFY 49.06
  • LNTH 37.75
  • Support Level
  • KFY $73.05
  • LNTH $53.10
  • Resistance Level
  • KFY $75.75
  • LNTH $55.69
  • Average True Range (ATR)
  • KFY 1.25
  • LNTH 1.85
  • MACD
  • KFY -0.13
  • LNTH 0.58
  • Stochastic Oscillator
  • KFY 17.00
  • LNTH 23.45

About KFY Korn Ferry

Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: